These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34943713)

  • 1. How to Combat Gram-Negative Bacteria Using Antimicrobial Peptides: A Challenge or an Unattainable Goal?
    Barreto-Santamaría A; Arévalo-Pinzón G; Patarroyo MA; Patarroyo ME
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943713
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Bobde SS; Alsaab FM; Wang G; Van Hoek ML
    Front Microbiol; 2021; 12():715246. PubMed ID: 34867843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience.
    Rizzetto G; Gambini D; Maurizi A; Molinelli E; De Simoni E; Pallotta F; Brescini L; Cirioni O; Offidani A; Simonetti O; Giacometti A
    Infez Med; 2023; 31(3):306-322. PubMed ID: 37701381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Disruptions of the Outer Membranes of Gram-Negative Bacteria by Rationally Designed Amphiphilic Antimicrobial Peptides.
    Gong H; Hu X; Liao M; Fa K; Ciumac D; Clifton LA; Sani MA; King SM; Maestro A; Separovic F; Waigh TA; Xu H; McBain AJ; Lu JR
    ACS Appl Mater Interfaces; 2021 Apr; 13(14):16062-16074. PubMed ID: 33797891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.
    Vishnepolsky B; Zaalishvili G; Karapetian M; Nasrashvili T; Kuljanishvili N; Gabrielian A; Rosenthal A; Hurt DE; Tartakovsky M; Grigolava M; Pirtskhalava M
    Pharmaceuticals (Basel); 2019 Jun; 12(2):. PubMed ID: 31163671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections.
    Yadav N; Chauhan VS
    Adv Colloid Interface Sci; 2024 Nov; 333():103282. PubMed ID: 39276418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coevolution of Resistance Against Antimicrobial Peptides.
    Baindara P; Ghosh AK; Mandal SM
    Microb Drug Resist; 2020 Aug; 26(8):880-899. PubMed ID: 32119634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomic-Resolution Structures and Mode of Action of Clinically Relevant Antimicrobial Peptides.
    Bhattacharjya S; Mohid SA; Bhunia A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR Structures and Interactions of Antimicrobial Peptides with Lipopolysaccharide: Connecting Structures to Functions.
    Bhattacharjya S
    Curr Top Med Chem; 2016; 16(1):4-15. PubMed ID: 26139110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to antimicrobial peptides in Gram-negative bacteria.
    Gruenheid S; Le Moual H
    FEMS Microbiol Lett; 2012 May; 330(2):81-9. PubMed ID: 22339775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Challenges of Antimicrobial Peptides for Therapeutic Applications.
    Chen CH; Lu TK
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31941022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.
    Nawrocki KL; Crispell EK; McBride SM
    Antibiotics (Basel); 2014 Oct; 3(4):461-92. PubMed ID: 25419466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining and Statistical Modeling of Natural and Variant Class IIa Bacteriocins Elucidate Activity and Selectivity Profiles across Species.
    Tresnak DT; Hackel BJ
    Appl Environ Microbiol; 2020 Oct; 86(22):. PubMed ID: 32917749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Peptides: Virulence and Resistance Modulation in Gram-Negative Bacteria.
    Duperthuy M
    Microorganisms; 2020 Feb; 8(2):. PubMed ID: 32092866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.
    Lee H; Lim SI; Shin SH; Lim Y; Koh JW; Yang S
    ACS Omega; 2019 Sep; 4(13):15694-15701. PubMed ID: 31572872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria.
    Chung PY; Khanum R
    J Microbiol Immunol Infect; 2017 Aug; 50(4):405-410. PubMed ID: 28690026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurrecting inactive antimicrobial peptides from the lipopolysaccharide trap.
    Mohanram H; Bhattacharjya S
    Antimicrob Agents Chemother; 2014; 58(4):1987-96. PubMed ID: 24419338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
    Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
    Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defensive remodeling: How bacterial surface properties and biofilm formation promote resistance to antimicrobial peptides.
    Nuri R; Shprung T; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3089-100. PubMed ID: 26051126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.